Visual acuity outcome in patients with diabetic maculopathy

The purpose of this study is to follow up visual acuity in patients diagnosed with clinically significant macular edema and treated by an intravitreal injection of triamcinolone acetonide or in combination with bevacizumab. The working method: based on the selectivity criteria we involved 295 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Serban, R, Cioboata, M, Chiotan, C, Cornăcel, C, Liora, R, Anghelie, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2014
Materias:
Case Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391359/
https://www.ncbi.nlm.nih.gov/pubmed/25870678
_version_ 1782365814426435584
author Serban, R
Cioboata, M
Chiotan, C
Cornăcel, C
Liora, R
Anghelie, A
author_facet Serban, R
Cioboata, M
Chiotan, C
Cornăcel, C
Liora, R
Anghelie, A
author_sort Serban, R
collection PubMed
description The purpose of this study is to follow up visual acuity in patients diagnosed with clinically significant macular edema and treated by an intravitreal injection of triamcinolone acetonide or in combination with bevacizumab. The working method: based on the selectivity criteria we involved 295 patients (460 eyes), divided into 2 groups according to the treatment administered and one control group. The results showed a better preservation of the functional parameter for the group of patients treated with intravitreal injection of triamcinolone acetonide and bevacizumab. Abbreviations: VA = visual acuity, VA0 = visual acuity at study entry, WESDR = Wisconsin epidemiological study of diabetic retinopathy, ETDRS = Early treatment diabetic retinopathy study, OCT = optical coherence tomography
format Online
Article
Text
id pubmed-4391359
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-43913592015-04-13 Visual acuity outcome in patients with diabetic maculopathy Serban, R Cioboata, M Chiotan, C Cornăcel, C Liora, R Anghelie, A J Med Life Case Presentations The purpose of this study is to follow up visual acuity in patients diagnosed with clinically significant macular edema and treated by an intravitreal injection of triamcinolone acetonide or in combination with bevacizumab. The working method: based on the selectivity criteria we involved 295 patients (460 eyes), divided into 2 groups according to the treatment administered and one control group. The results showed a better preservation of the functional parameter for the group of patients treated with intravitreal injection of triamcinolone acetonide and bevacizumab. Abbreviations: VA = visual acuity, VA0 = visual acuity at study entry, WESDR = Wisconsin epidemiological study of diabetic retinopathy, ETDRS = Early treatment diabetic retinopathy study, OCT = optical coherence tomography Carol Davila University Press 2014 /pmc/articles/PMC4391359/ /pubmed/25870678 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Presentations
Serban, R
Cioboata, M
Chiotan, C
Cornăcel, C
Liora, R
Anghelie, A
Visual acuity outcome in patients with diabetic maculopathy
title Visual acuity outcome in patients with diabetic maculopathy
title_full Visual acuity outcome in patients with diabetic maculopathy
title_fullStr Visual acuity outcome in patients with diabetic maculopathy
title_full_unstemmed Visual acuity outcome in patients with diabetic maculopathy
title_short Visual acuity outcome in patients with diabetic maculopathy
title_sort visual acuity outcome in patients with diabetic maculopathy
topic Case Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391359/
https://www.ncbi.nlm.nih.gov/pubmed/25870678
work_keys_str_mv AT serbanr visualacuityoutcomeinpatientswithdiabeticmaculopathy
AT cioboatam visualacuityoutcomeinpatientswithdiabeticmaculopathy
AT chiotanc visualacuityoutcomeinpatientswithdiabeticmaculopathy
AT cornacelc visualacuityoutcomeinpatientswithdiabeticmaculopathy
AT liorar visualacuityoutcomeinpatientswithdiabeticmaculopathy
AT angheliea visualacuityoutcomeinpatientswithdiabeticmaculopathy

Ejemplares similares